News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Biomed celebra su Jornada Anual 2025
GENESIS Biomed holds its 2025 Annual Symposium at the Parc Científic de Barcelona
Communication · Corporate
The event featured the intervention of Josep Lluís Falcó, CEO of the company, who addressed the…
BioSintNA - Presentación Plan (Sodena)
Sodena leads BioSintNA, the Synthetic Biology Business Plan in Navarra
Healthcare · Access to innovation
Navarre takes a strategic step toward the future with the launch of BioSintNA, an ambitious…
presentacion_manos_seguras_3_0_big
An Innovative App developed at San Cecilio Clinical Hospital with Support from ibs.GRANADA Improves Hand Hygiene in Healthcare Settings
Healthcare
Manos Seguras 3.0, designed in collaboration with a Granada-based startup and supported by ibs.…
DavidSegarra MariaEugeniaZarabozo
aptaTargets transferred ApTOLL to Merck
Healthcare · Access to innovation · Financing
ApTOLL completed a Phase 1b/2 clinical trial for acute ischemic stroke with positive results. Merck…
El equipo de ALLOX en su laboratorio en el Parque Científico de Barcelona. Foto
ALLOX, the startup exploring allosterism to revolutionize drug development
Healthcare · Access to innovation
Recently established at the Barcelona Science Park, ALLOX is harnessing cutting-edge technology…
Inversión biotecnología AseBio
Kadans becomes a new member of the Spanish Association of Science and Technology Parks
Healthcare
Kadans Science Partner, a European leader in innovation campus development, has joined the…
cdti india.
Gate2Brain secures over €700,000 in CDTI Multipaís funding to advance a novel therapy against pediatric brain tumors in collaboration with India
Healthcare
Gate2Brain secures key funding to advance its groundbreaking pediatric brain tumor therapy
Repronovo investment YSIOS
Repronovo raises $65 million Series A financing to advance phase 2 clinical trials of novel therapies in reproductive medicine and women’s health
Healthcare · Financing
Round led by Jeito Capital, co-led by AXA IM Alts and M Ventures, with strong syndicate support…
Planta 53 Biologics
Case study: Development of the new GMP plant of 53Biologics
Healthcare
53Biologics strengthens its biopharmaceutical capacity in Spain with a new GMP facility in…